a rapid motion straight into the skin at a 90 degree angle. Tape needle in place with sterile tape.
•
Repeat this step if you have a second infusion site.
•
Check for proper needle placement by pulling back on the syringe plunger to check for blood return in the tubing of the needle set.
•
If blood is seen in the tubing, remove and discard the subcutaneous needle and repeat steps 3, 5 and 6 with a new subcutaneous needle and infusion site.
•
Secure the needle set in place by applying a sterile protective dressing over the site. If more than one site is used, repeat the steps
1.
Administer the hyaluronidase (Labeled as “HY”):
•
Administer the HY at an initial rate per infusion site of approximately 1 to 2 mL per minute and increase as tolerated. Divide the contents equally between sites, if more than one site is used.
•
Remove the syringe from the needle set, after infusing all of the content of the syringe.
•
Attach the pump tubing or syringe filled with the IG to the same needle set.
1.
Administer the immune globulin (Labeled as “IG”:
Within 10 minutes of completing the infusion of the HY, start the pump to administer the IG.
•
Flush infusion tubing up to the needle hub with normal saline or Dextrose 5% in water (D5W) at the end of infusion, if directed by your healthcare professional.
1.
Remove subcutaneous needle(s) from the infusion site(s):
•
Remove the needle set by loosening the tape on all edges.
•
Pull the needle wings straight up and out.
•
Gently press a small piece of gauze over the needle site and cover with a dressing.
•
Throw away the needle(s) into the sharps container.
1.
Record the infusion:
•
Remove the peel-off label from HYQVIA vial(s), which has the product lot number and expiration date, and place the label in your treatment record/ infusion log
•
Write down the date, time, dose, site(s) of infusion (to assist in rotating sites) and any reactions after each infusion.
•
Throw away the disposable supplies, vials, and unused product as recommended by your healthcare professional.
Baxalta and Hyqvia are trademarks of Baxalta Incorporated.
Patented: please see www.baxalta.com/productpatents/
Baxalta US Inc.
Westlake Village, CA 91362 USA
U.S. License No. 2020
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL
Recombinant Human Hyaluronidase 1.25 mL Infuse 1st Vial Label
Recombinant Human Hyaluronidase
Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
1.25 mL
160 units per mL
Lot/Expiry date:
Recombinant Human Hyaluronidase 2.5 mL Infuse 1st Vial Label
Recombinant Human Hyaluronidase
Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
2.5 mL
160 units per mL
Lot:
Expiry date:
Recombinant Human Hyaluronidase 5 mL Infuse 1st Vial Label
Recombinant Human Hyaluronidase
Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
5 mL
160 units per mL
Lot:
Expiry date:
Recombinant Human Hyaluronidase 10 mL Infuse 1st Vial Label
Recombinant Human Hyaluronida